{"slug":"retatrutide-gut","verification":{"valid":true,"entries":2,"head":"d3967599856feb62114e5f5760d98fe4c80e7316893c4eb98b0008f5b302c626"},"energy":{"passes":2,"tokens_in":12716,"tokens_out":3289,"tokens_total":16005,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"d3967599856feb62114e5f5760d98fe4c80e7316893c4eb98b0008f5b302c626"},"provenance":[{"ts":"2026-06-30T00:59:05.487Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Retatrutide for Gut\nSlug: retatrutide-gut\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"retatrutide\",\"name\":\"Retatrutide\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"retatrutide\",\"name\":\"Retatrutide\",\"section_title\":\"Why Retatrutide might help you\",\"layer\":\"metabolic load / body weight\",\"steps\":[\"**What keeps failing:** Excess body weight multiplies compressive load on spine, hips, knees, and plantar fascia.\",\"**What Retatrutide is studied to do:** Studied for GLP-1/GIP/glucagon-driven weight loss — less mechanical load, not direct disc regeneration.\",\"**Therefore for you:** If that layer is part of your problem, Retatrutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"],\"prose\":\"1. **What keeps failing:** Excess body weight multiplies compressive load on spine, hips, knees, and plantar fascia.\\n2. **What Retatrutide is studied to do:** Studied for GLP-1/GIP/glucagon-driven weight loss — less mechanical load, not direct disc regeneration.\\n3. **Therefore for you:** If that layer is part of your problem, Retatrutide is discussed because it targets repair (metabolic load / body weight) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_c","response":"{\n  \"slug\": \"retatrutide-gut\",\n  \"title\": \"Retatrutide for Gut: Evidence-Graded Look at Metabolic Load Reduction\",\n  \"body\": \"## What's breaking down\\n\\nExcess body weight places ongoing mechanical and metabolic stress on multiple systems, including the gut. When body mass increases, intra-abdominal pressure rises, which can alter gut motility, increase reflux risk, and compound issues with digestion and nutrient absorption over time. This creates a cycle where degeneration (sustained load and inflammation) outpaces natural repair processes in the gastrointestinal tract. Retatrutide targets one upstream layer—body weight—through GLP-1, GIP, and glucagon receptor agonism, studied primarily for weight reduction rather than direct gut tissue repair.\\n\\n## Why Retatrutide might help you\\n\\n1. **What keeps failing:** Excess body weight multiplies compressive load on spine, hips, knees, and plantar fascia. The same excess mass increases intra-abdominal pressure that can impair gut motility and heighten mechanical strain on the digestive tract.\\n\\n2. **What Retatrutide is studied to do:** Studied for GLP-1/GIP/glucagon-driven weight loss — less mechanical load, not direct disc regeneration or direct gut lining repair.\\n\\n3. **Therefore for you:** If excess weight forms part of your gut-related load, Retatrutide is discussed because it targets repair (metabolic load / body weight) — not because it masks symptoms or repairs gut tissue directly.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **Retatrutide** → metabolic load / body weight\\n\\n## What the evidence actually shows\\n\\nHuman trials of retatrutide (phase 2, n=338 adults with obesity) showed dose-dependent weight loss reaching up to 24.2% at 48 weeks on the highest dose versus 2.1% on placebo (human tier). Gastrointestinal adverse events were the most common, dose-related, and mostly mild","tokens_in":12716,"tokens_out":3289,"cost":0,"prev":"genesis","hash":"e2110148154586baecd9946bdc4f8a13a835b177714dc2267585256c7319e685"},{"ts":"2026-07-17T02:41:17.406Z","model":"owner","action":"voxel_divide","prompt":"","input":"retatrutide-gut","response":"23 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"e2110148154586baecd9946bdc4f8a13a835b177714dc2267585256c7319e685","hash":"d3967599856feb62114e5f5760d98fe4c80e7316893c4eb98b0008f5b302c626"}]}